GlassScriptPhysician profile
Robin S Disler
NPI 1366404493
$568.86
in general payments reported to CMS, 2019-2025
17 companies · $13.94 in 2025
The $13.94 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.76 · 2020: $11.72 · 2021: $164 · 2022: $77.59 · 2023: $160 · 2024: $64.80 · 2025: $13.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $115.25 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $61.04 | 2019-2024 | Prolia, Evenity, Repatha |
| Abbvie INC. | $54.00 | 2021-2023 | Vraylar |
| Xeris Pharmaceuticals, INC. | $46.13 | 2021-2022 | |
| Abbott Laboratories | $40.68 | 2023-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $33.33 | 2023 | Trulicity, Mounjaro |
| Glaxosmithkline, LLC. | $31.41 | 2019-2021 | |
| Esperion Therapeutics, INC. | $30.83 | 2021-2022 | |
| Amarin Pharma, INC. | $27.39 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $26.32 | 2021-2025 | Farxiga |
| Dexcom, INC. | $18.60 | 2023 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $15.71 | 2021 | |
| Merck Sharp & Dohme LLC | $15.34 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $14.37 | 2024 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $14.04 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.01 | 2023 | |
| Currax Pharmaceuticals LLC | $11.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Disler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.